日本語 
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
Rakuten Yoyakusuri partners March on online treatment
March, which provides an online medical consultation system that takes responsibility for…
B-MAP and Ignis Explore Medical-Skynet AI for Clinics
B-MAP Inc. is pleased to announce that it has today signed a…
Takeda Commits Over $1.7 Billion to AI-Driven Drug Discovery in Major Partnership with Iambic
One of Japan's largest pharmaceutical companies, Takeda Pharmaceutical Company, has ramped up…
From Reactive to Predictive Care: How AI, Sensors, and Data Are Redefining Global Healthcare
Healthcare has always been good at reacting. Someone feels pain, something breaks,…
Quali Inc. Raises ¥1.8B in Series A, Begins Operations
Quali Corporation (hereinafter, Quali) has raised 1.8 billion yen in its Series…
Fujitsu Japan and JMDC Team Up on Healthcare Data
Fujitsu Japan and JMDC announced that they officially began a collaboration on…
Eisai and Henlius Sign Japan Rights Deal for Serplulimab
Eisai and Shanghai Henlius Biotech have signed an exclusive commercialization agreement and…
Fujirebio and Sysmex form Dementia Testing Sales Alliance
Fujirebio Holdings, Inc., a consolidated subsidiary of H.U. Group Holdings, Inc. and…
English